Menu

Search

Conor Meehan

Conor Meehan

Senior Lecturer in Microbiology, Nottingham Trent University
I am a molecular epidemiologist who looks at the transmission of bacteria and viruses between humans. My work focusses primarily on Mycobacterium tuberculosis but also on many other pathogens.

I graduated from NUI Maynooth, Ireland with a BSc in computational biology and genetics followed by a PhD in NUI Galway researching HIV transmission and drug resistance. I then undertook a 3 year postdoctoral fellowship in Dalhousie University, Canada looking at how bacteria swap their genetic material and how the human microbiome communities evolve. After this, in 2014 I joined the Institute of Tropical Medicine, Belgium as a research fellow. There I led projects on Mycobacterium tuberculosis and other pathogens of the same genus, mostly looking at their transmission in high burden countries and how best to use genomics to improve public health initiatives. I am now a senior lecturer in microbiology at Nottingham Trent University within the AROM microbiology group where my group looks at both the evolution of bacterial pathogens and human associated microbiomes.

Which infectious disease is likely to be the biggest emerging problem in 2025?

Dec 26, 2024 09:07 am UTC| Insights & Views Health

COVID emerged suddenly, spread rapidly and killed millions of people around the world. Since then, I think its fair to say that most people have been nervous about the emergence of the next big infectious disease be that...

Gut microbiome: meet Roseburia intestinalis — the energy-producing bacterium that helps us fight against disease

Mar 18, 2024 09:01 am UTC| Health

The hundreds of species of microorganisms that comprise the microbiome all have different, unique roles. One of the important functions that takes place in the gut is the production of short-chain fatty acids. These...

1 

Economy

Europe Confronts Rising Competitive Pressure as China Accelerates Export-Led Growth

Europe is facing growing competitive pressure from China as Beijing intensifies its export-driven growth strategy, a shift Goldman Sachs says is reshaping the outlook for several major European industries. The bank...

Citi Sets Bullish 2026 Target for STOXX 600 as Fiscal Support and Monetary Easing Boost Outlook

Citigroup has raised its outlook for European equities, setting a 2026 year-end target of 640 for the STOXX 600 index. The forecast suggests a potential 10.5% upside from Thursdays close, reflecting growing confidence in...

Dollar Weakens Ahead of Expected Federal Reserve Rate Cut

The U.S. dollar hovered near a five-week low on Friday as global investors positioned themselves for a widely anticipated Federal Reserve rate cut next week. The greenback remained under pressure across major currencies,...

RBI Cuts Repo Rate to 5.25% as Inflation Cools and Growth Outlook Strengthens

The Reserve Bank of India (RBI) delivered a widely expected 25-basis-point cut to its key repo rate on Friday, lowering it from 5.50% to 5.25% as policymakers moved to support economic growth amid easing inflation. The...

Asian Markets Mixed as RBI Cuts Rates and BOJ Signals Possible Hike

Asian stock markets traded mixed on Friday as investors assessed contrasting signals from major central banks, while most regional indexes held steady ahead of key U.S. inflation data. Market sentiment was shaped by Indias...

Politics

Cuba Reaffirms Anti-Drug Cooperation as Tensions Rise in the Caribbean

Cuban authorities announced that the island is intensifying its fight against narcotics trafficking in the Caribbean, emphasizing ongoing cooperation with the U.S. Coast Guard despite heightened political tensions and an...

Drones Spotted Near Zelenskiy’s Flight Path in Ireland Trigger Security Alert

An Irish naval vessel detected as many as five drones operating close to the flight path of Ukrainian President Volodymyr Zelenskiys aircraft as he arrived in Ireland for a state visit, according to local media reports on...

Australia Progresses AUKUS Review as U.S. Affirms Strong Support

Australia is moving forward with the newly received United States review of the AUKUS nuclear-powered submarine partnership, signalling renewed confidence in the trilateral defence pact with the U.S. and the United...

Trump Administration Tightens H-1B Visa Vetting With New Focus on Free Speech and Censorship

The Trump administration has introduced stricter vetting measures for H-1B visa applicants, targeting professionals in highly skilled fields often recruited by major U.S. tech companies. According to an internal State...

China Urged to Prioritize Economy Over Territorial Ambitions, Says Taiwan’s President Lai

Taiwan President Lai Ching-te has urged Chinese President Xi Jinping to direct his focus toward revitalizing Chinas weakening economy rather than pursuing territorial expansion, highlighting widening economic contrasts...

Science

Senate Sets December 8 Vote on Trump’s NASA Nominee Jared Isaacman

The U.S. Senate Commerce Committee announced it will vote on December 8 on President Donald Trumps renewed nomination of private astronaut and tech entrepreneur Jared Isaacman to lead NASA. Isaacman, known for his...

NASA Cuts Boeing Starliner Missions as SpaceX Pulls Ahead

NASA has significantly scaled back Boeings Starliner program after years of technical issues and delays, announcing that the next Starliner mission to the International Space Station (ISS) will fly without astronauts. The...

Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission

Blue Origins massive New Glenn rocket marked a major milestone as it completed its first mission for paying customers, sending two NASA satellites toward Mars and successfully landing its reusable booster at sea. The...

Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment

Cogent Biosciences (NASDAQ: COGT) shares skyrocketed over 120% after the biotech company announced groundbreaking results from its Phase 3 PEAK trial evaluating bezuclastinib in combination with sunitinib for patients with...

Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage

U.S. President Donald Trump and German pharmaceutical company Merck KGaA have announced a groundbreaking deal aimed at lowering the cost of in-vitro fertilization (IVF) treatments while boosting access to fertility care in...

Technology

EU Prepares Antitrust Probe Into Meta’s AI Integration on WhatsApp

The European Commission is reportedly preparing to launch a new antitrust investigation into Meta Platforms Inc. (NASDAQ: META) over the companys recent rollout of artificial intelligence features within WhatsApp....

Sam Altman Reportedly Explored Funding for Rocket Venture in Potential Challenge to SpaceX

OpenAI CEO Sam Altman reportedly explored raising significant capital to acquire or partner with a rocket company, a move that could have created direct competition with Elon Musks SpaceX. According to a report from the...

Wikipedia Pushes for AI Licensing Deals as Jimmy Wales Calls for Fair Compensation

Wikipedia is seeking additional licensing deals with major technology companies to address the growing financial burden caused by artificial intelligence firms heavily scraping its platform, according to co-founder Jimmy...

Firelight Launches as First XRP Staking Platform on Flare, Introduces DeFi Cover Feature

Firelight reaches 25M XRP deposit cap within hours of launch; ushers in a new era for decentralized XRP staking. A new XRP staking platform, Firelight, has officially launched on the Flare blockchain, marking the first...

OpenAI Moves to Acquire Neptune as It Expands AI Training Capabilities

OpenAI has confirmed plans to acquire Neptune, a startup known for its advanced tools that help companies track, monitor, and optimize AI model training workflows. Although the company did not release the financial details...
  • Market Data
Close

Welcome to EconoTimes

Sign up for daily updates for the most important
stories unfolding in the global economy.